Psycheceutical, Inc. has announced it has entered into a strategic agreement with Vici Health Sciences, known for providing pharmaceutical clients with tools to innovate and grow through new product development.…
Read More Esteemed neurosurgeon to participate in strategy, direction for development of novel psychedelic therapy innovations.
Read More Psycheceutical, Inc., today announced the company has been fully acquired by Blue Water Ventures International, Inc. (OTCPK: BWVI).
Read More Psycheceutical, Inc., today announced the addition of Zachary Clayton, PhD, to its scientific advisory board.
Read More Psycheceutical, Inc., today announced the growth of its esteemed board with two new appointments, Dr. Ronald Aung-Din and Dr. John Kutzko.
Read More